AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studySystematic reviewPublished in a peer-reviewed journal
The Role of AIM2 in Immune Cells Related to Multiple Sclerosis
A systematic review found evidence suggesting that AIM2 is involved in the development of multiple sclerosis (MS) through its role in immune cell activities and signaling pathways.
- Tags
- #Other
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Moderate
- Outcome
- Not reported
Why it matters
Understanding AIM2's involvement in MS could lead to insights into the disease's mechanisms and potential therapeutic targets. However, the review does not present original research data to establish direct causation.
What this does not prove
As a review article, this study synthesizes existing literature without primary research data, limiting its direct application in understanding MS mechanisms.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-24
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Other
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceAIM2 as a therapeutic target in autoimmunity: balancing inflammasome inhibition with immune homeostasis. ↗DOI: 10.1016/j.autrev.2026.104218
Supporting passages (7)
study designPublication types: Journal Article; Review
subjectsWe examine the role of AIM2 in different immune cell populations, its effects on multiple downstream signaling pathways, and its complex association with autoimmune diseases such as psoriasis, rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.
research categoriesThis comprehensive review synthesizes current understanding of AIM2 biology.
findingsWe examine the role of AIM2 in different immune cell populations, its effects on multiple downstream signaling pathways, and its complex association with autoimmune diseases such as psoriasis, rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.
publication datePublication date: 2026-10-24
limitationsTitle: AIM2 as a therapeutic target in autoimmunity: balancing inflammasome inhibition with immune homeostasis.
peer reviewedPublication types: Journal Article; Review
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.